{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:33:03Z","timestamp":1760059983981,"version":"build-2065373602"},"reference-count":32,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>We present a rare case of delayed retrobulbar and adrenal metastases from renal cell carcinoma (RCC), diagnosed 5.5 years after radical nephrectomy. The patient exhibited symptomatic orbital involvement, with imaging revealing a hypervascular retrobulbar mass and an incidental right adrenal lesion, indicative of an oligometastatic state. Owing to the patient\u2019s refusal of surgical resection, stereotactic ablative radiotherapy (SABR) was delivered to the retrobulbar lesion at a total dose of 40 Gy in five fractions, concurrently with immune checkpoint inhibitor therapy. Treatment planning prioritized sparing adjacent critical structures, including the optic chiasm and brainstem. Follow-up over 4 years demonstrated sustained radiologic stability and volume reduction in both metastatic lesions without evidence of progression. This case underscores the potential efficacy of SABR in achieving durable local control of RCC metastases, particularly in anatomically constrained regions where surgery is unfeasible. Moreover, it highlights the value of a multidisciplinary, multimodal treatment approach incorporating advanced radiotherapy techniques and systemic immunotherapy. Lastly, it reinforces the importance of prolonged surveillance in RCC survivors due to the potential for late metastatic recurrence at uncommon sites.<\/jats:p>","DOI":"10.3390\/life15081176","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T14:11:44Z","timestamp":1753366304000},"page":"1176","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stereotactic Ablative Radiotherapy for Delayed Retrobulbar Metastasis of Renal Cell Carcinoma: Therapeutic Outcomes and Practical Insights"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6115-2804","authenticated-orcid":false,"given":"Sang Jun","family":"Byun","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Urology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4835-4599","authenticated-orcid":false,"given":"Seung Gyu","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2962-7207","authenticated-orcid":false,"given":"Euncheol","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.11604\/pamj.2022.42.26.33578","article-title":"Rare metastatic sites of renal cell carcinoma: A case series","volume":"42","author":"Singla","year":"2022","journal-title":"Pan. Afr. Med. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.survophthal.2006.12.004","article-title":"Metastasis to the eye and orbit from renal cell carcinoma--a report of three cases and review of literature","volume":"52","author":"Shome","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Palmisciano, P., Ferini, G., Ogasawara, C., Wahood, W., Bin Alamer, O., Gupta, A.D., Scalia, G., Larsen, A.M.G., Yu, K., and Umana, G.E. (2021). Orbital Metastases: A Systematic Review of Clinical Characteristics, Management Strategies, and Treatment Outcomes. Cancers, 14.","DOI":"10.3390\/cancers14010094"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/ICU.0b013e3282c5077c","article-title":"Metastatic tumors of the orbit and ocular adnexa","volume":"18","author":"Ahmad","year":"2007","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e25586","DOI":"10.1097\/MD.0000000000025586","article-title":"Extremely delayed solitary cerebral metastasis in patient with T1N0M0 renal cell carcinoma after radical nephrectomy: Case report and literature review","volume":"100","author":"Choo","year":"2021","journal-title":"Medicine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.31156","article-title":"Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)","volume":"124","author":"Siva","year":"2018","journal-title":"Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ijrobp.2011.02.040","article-title":"Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma","volume":"82","author":"Zelefsky","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"102660","DOI":"10.1016\/j.fjurol.2024.102660","article-title":"Stereotactic body radiation therapy for primary renal cell carcinoma: A review on behalf of the CC-AFU","volume":"34","author":"Bentahila","year":"2024","journal-title":"Fr. J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med. Phys."},{"key":"ref_11","first-page":"126","article-title":"Late recurrences of renal cell carcinoma at unusual sites: Implications for patient management","volume":"10","author":"Venugopal","year":"2012","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Marra, C., Losco, L., Ceccaroni, A., Pentangelo, P., Troisi, D., and Alfano, C. (2023). Metastatic Renal Cell Carcinoma to the Soft Tissue 27 Years after Radical Nephrectomy: A Case Report. Medicina, 59.","DOI":"10.3390\/medicina59010150"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s13256-021-03098-5","article-title":"Renal cell carcinoma with unusual metachronous metastasis up to 22 years after nephrectomy: Two case reports","volume":"15","author":"Bruckschen","year":"2021","journal-title":"J. Med. Case. Rep."},{"key":"ref_14","first-page":"e2113","article-title":"A case report of renal cell carcinoma metastasis revealed through late-onset thyroid nodules","volume":"7","author":"Zamani","year":"2024","journal-title":"Cancer Rep."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lou, Y., Guo, K., and Zheng, S. (2023). Case Report: Pancreatic metastasis of renal cell carcinoma 16 years after nephrectomy. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1091635"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s40792-024-02036-z","article-title":"Gastric metastasis from renal cell carcinoma with submucosal invasion treated by surgical full-thickness resection: A case report","volume":"10","author":"Magara","year":"2024","journal-title":"Surg. Case Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zheng, Z., Yang, T., Li, Y., Qu, P., Shao, Z., Wang, Y., Chang, W., Umar, S.M., Wang, J., and Ding, N. (2024). A future directions of renal cell carcinoma treatment: Combination of immune checkpoint inhibition and carbon ion radiotherapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1428584"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0360-3016(95)02029-2","article-title":"A review of human cell radiosensitivity in vitro","volume":"34","author":"Deschavanne","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jcb.25283","article-title":"Hypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells","volume":"117","author":"Chen","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/MCB.25.13.5675-5686.2005","article-title":"Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma","volume":"25","author":"Raval","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00109-014-1180-z","article-title":"The role of HIF1\u03b1 in renal cell carcinoma tumorigenesis","volume":"92","author":"Gudas","year":"2014","journal-title":"J. Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhang, J., Zhang, Y., Mo, F., Patel, G., Butterworth, K., Shao, C., and Prise, K.M. (2021). The Roles of HIF-1\u03b1 in Radiosensitivity and Radiation-Induced Bystander Effects Under Hypoxia. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.637454"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2024.255","article-title":"Role of HIF-1\u03b1 in the Responses of Tumors to Radiotherapy and Chemotherapy","volume":"57","author":"Song","year":"2025","journal-title":"Cancer Res. Treat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2519::AID-CNCR26>3.0.CO;2-E","article-title":"Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts","volume":"80","author":"Ning","year":"1997","journal-title":"Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.3390\/curroncol29100619","article-title":"Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All\/Multiple Sites for Oligometastatic Renal Cell Cancer Patients","volume":"29","author":"Ma","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_26","first-page":"29","article-title":"Stereotactic body radiation therapy (SBRT) for metastatic renal cell carcinoma: A multi-institutional experience","volume":"7","author":"Singh","year":"2020","journal-title":"J. Radiosurg. SBRT"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S1470-2045(22)00656-8","article-title":"5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: An individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)","volume":"23","author":"Siva","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Villafuerte, C.J.Q., and Swaminath, A. (2024). Stereotactic Body Radiotherapy for Renal Cell Carcinoma-A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings. Cancers, 16.","DOI":"10.3390\/cancers16193334"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/COC.0000000000000622","article-title":"Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors","volume":"43","author":"He","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_30","first-page":"104","article-title":"Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?","volume":"18","author":"Andratschke","year":"2019","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100692","DOI":"10.1016\/j.adro.2021.100692","article-title":"Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma","volume":"6","author":"Schoenhals","year":"2021","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2016.03.067","article-title":"Can immunostimulatory agents enhance the abscopal effect of radiotherapy?","volume":"62","author":"Levy","year":"2016","journal-title":"Eur. J. Cancer"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/8\/1176\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:15:34Z","timestamp":1760033734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/8\/1176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["life15081176"],"URL":"https:\/\/doi.org\/10.3390\/life15081176","relation":{},"ISSN":["2075-1729"],"issn-type":[{"type":"electronic","value":"2075-1729"}],"subject":[],"published":{"date-parts":[[2025,7,24]]}}}